Meet The Monument Discovery Award team
The Monument Discovery Award brings
together a world-class team of researchers at the University of
Oxford, aiming to find a cure for Parkinson's.
The award is our biggest ever research grant at
£5million over 5 years.
Dr Richard Wade-Martins
Head,
Laboratory of Molecular
Neurodegeneration,
University of
Oxford
Dr Richard Wade-Martins is the Discovery Group Leader and heads
the Laboratory of Molecular Neurodegeneration at the University of
Oxford.
Richard graduated from the University of Cambridge in 1995 in
Natural Sciences. He has since worked at the Wellcome Trust Centre
for Human Genetics in Oxford, and at Harvard Medical
School.
Richard's research focuses on understanding what happens inside
cells affected by neurodegenerative diseases, such as
Parkinson's.
His work involves studying human brain tissue, investigating how
nerve cells work, and developing better animal models that more
closely resemble human conditions.
Richard
Wade-Martins - University of Oxford profile
Dr Kevin Talbot
Consultant Neurologist,
Department of
Clinical Neurology, University of
Oxford
Dr Kevin Talbot is the Deputy Leader of the Discovery Award
team.
Kevin's clinical focus is on neurodegenerative conditions, and
he regularly sees people with Parkinson's and related
conditions.
His research interests focus on how nerve cells survive in
mouse and fly versions of human conditions.
Kevin also runs clinical trials for neurodegenerative
conditions, looking at differences in how people's brains work
using imaging.
Kevin
Talbot - University of Oxford profile
Professor Chris Ponting
Professor of
Genomics,
MRC Functional Genomics
Unit, University of Oxford
Professor Chris Ponting is leading Theme 1 of the Discovery Award -
exploring what changes occur inside the nerve cells that are lost
in Parkinson's.
Chris's research focuses on understanding how genes work. He was
a major participant in the human genome project - an international
effort to identify all the genes found in human DNA.
Chris now works to uncover information that tells us about the
genetic risks to human diseases. Understanding the genetic basis of
disease will provide important pieces to the research puzzle, which
- when complete – will lead to improved diagnoses, drugs or
therapy.
Chris
Ponting - University of Oxford profile
Professor Paul Bolam
Professor of
Neuropharmacology,
University of
Oxford
Professor Paul Bolam is leading Theme 2 of the Discovery Award -
developing new and better animal models that truly reflect
Parkinson's.
Paul's research focuses on how nerve cells work together in
complex circuits inside the brain. Each cell can simultaneously
communicate with thousands of other cells. Paul studies how these
networks function in the normal brain, and how the networks fall
apart when nerve cells die.
His work also attempts to understand why some types of nerve
cells are more susceptible in Parkinson's than others.
Paul Bolam -
University of Oxford profile
Dr Michele Hu
Consultant
Neurologist,
Department of Clinical
Neurology, University of Oxford
Dr Michele Hu is leading Theme
3 of the Discovery Award - studying people with and without
Parkinson's to find new ways of diagnosing the condition earlier,
before symptoms develop.
Michele's interest in Parkinson's started in 1998 when she was
awarded an Action Research Training Fellowship to study brain
function in people with Parkinson's.
Since commencing her consultant appointment in 2005, Michele has
set up a clinical Parkinson's and movement disorders service in
Milton Keynes Hospital NHS Foundation Trust.
Michele Hu
- University of Oxford profile
How you can help
We are closer than ever to finding a cure, but we need your
help.
Our research is totally dependent on voluntary donations.
One
donated brain can be used in up to 50 research studies. Help us
make 2010 a breakthrough year by signing up.
- email
-
Share